Messinger Michael purchased $2K of ICU
Messinger Michael (Chief Financial Officer) purchased 750 shares of SeaStar Medical Holding Corp (ICU) at $3.27 on 2026-08-18.
How this was made
The 30-second read
Why it matters
Traders may note the CFO’s open-market buy, but the disclosed dollar value is too small to materially alter valuation expectations.
Market read
A small CFO open-market buy is a mild sentiment datapoint with limited trading impact.
What to watch
The filing does not indicate a 10b5-1 plan and does not provide context on prior buying patterns, option exercises, or whether the CFO’s compensation structure drives periodic purchases.
Background
The article is an SEC Form 4 insider transaction disclosure for SeaStar Medical Holding Corp (ICU).
Ticker impact
CFO Michael Messinger filed a Form 4 open-market purchase of 750 shares at $3.2700 on 2026-08-18, totaling $2,452.50.
Low likelihood of a near-term price move; any effect is likely sentiment-driven and limited.
The transaction size is small ($2.5k) and is not a 10b5-1 plan; insider buys can be informative, but this disclosure alone typically lacks the scale to change fundamentals or guidance.
Market effects
No clear sector read-through from a single small insider buy.
None.
None.
Counterpoint
Insider purchases can be routine liquidity or diversification rather than a strong forward-looking signal, especially at small dollar amounts.
Key entities
- issuerSeaStar Medical Holding Corp
Subject of the Form 4 insider transaction disclosure.
- insiderMichael Messinger
Chief Financial Officer who purchased 750 shares open-market.
